Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Long-term tolvaptan cost-effective only in CHF patients needing high-dose furosemide
07 Feb 2022
While tolvaptan does not seem to provide a clear economic benefit in all patients with chronic heart failure (CHF), its use in those who require high-dose furosemide may be cost-effective, a recent study has found.
Long-term tolvaptan cost-effective only in CHF patients needing high-dose furosemide
07 Feb 2022
Sacubitril/valsartan equals enalapril, valsartan alone for preventing AF in HF
31 Jan 2022
Sacubitril/valsartan performs comparably as enalapril or valsartan alone in preventing atrial fibrillation (AF) occurrence in patients with heart failure (HF), reports a recent meta-analysis.